Join the MiRXES Team​

Be part of the team delivering world-leading multi-cancer early detection. MiRXES is a Singapore-headquartered biotechnology company that translates research discoveries to deliver world-leading multi-cancer early detection. We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China.

Our versatile platform technology and capabilities have broad applications in the discovery of biomarkers and diagnosis of diseases. We started with cancer, but are also addressing unmet clinical needs in cardiovascular, metabolic, and infectious diseases.

We are a Singapore-headquartered biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests.

Our story began in early 2000s when our founders pioneered a highly sensitive, specific and robust detection technology for microRNA (miRNA), the smallest genetic material ever found in human and other living organisms. Realizing the potential of miRNA-based clinical applications in solving unmet needs in cancer, cardiovascular, metabolic, and infectious diseases, we decided to bring our technology from lab to clinic.

In 2014, we spun off from Agency of Science, Technology and Research (A*STAR) to commercialise our technology and develop accurate multi-cancer early detection solutions and make them readily available and accessible to people who need them.

We believe that the future of healthcare will shift from treating the sick to preventive healthcare. Our science and innovation will continue as we are committed to changing lives by delivering preventive healthcare solutions to all.